| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | James H Lewis | |
| Max A Shapiro | |||
| P433 | issue | 3 | |
| P921 | main subject | hepatotoxicity | Q1349821 |
| P304 | page(s) | 477-505, v | |
| P577 | publication date | 2007-08-01 | |
| P1433 | published in | Clinics in liver disease | Q26842322 |
| P1476 | title | Causality assessment of drug-induced hepatotoxicity: promises and pitfalls | |
| P478 | volume | 11 |
| Q34660447 | A challenge for diagnosing acute liver injury with concomitant/sequential exposure to multiple drugs: can causality assessment scales be utilized to identify the offending drug? |
| Q46025868 | Acetaminophen-induced Acute Liver Failure is More Common and More Severe in Women. |
| Q24647134 | Acute liver failure including acetaminophen overdose |
| Q47594151 | Agreement Among Different Scales for Causality Assessment in Drug-Induced Liver Injury |
| Q37613520 | An Update on Drug-induced Liver Injury |
| Q34362116 | An integrated analysis of liver safety data from orlistat clinical trials |
| Q35526652 | Anti-tumour necrosis factor agent and liver injury: literature review, recommendations for management |
| Q83966463 | Azathioprine induced liver injury: a case report |
| Q33851671 | Bridging differences in outcomes of pharmacoepidemiological studies: design and first results of the PROTECT project |
| Q93140962 | Causality assessment: Which is best-expert opinion or RUCAM? |
| Q40995506 | Clinical and histological features of idiosyncratic liver injury: Dilemma in diagnosis of autoimmune hepatitis |
| Q38009719 | Clinical perspective: statins and the liver--harmful or helpful? |
| Q30277969 | Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic review |
| Q39523252 | Current challenges and controversies in drug-induced liver injury. |
| Q84814118 | Diagnosis: Liver biopsy differentiates DILI from autoimmune hepatitis |
| Q36799781 | Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct |
| Q26767516 | Drug-Induced Liver Toxicity and Prevention by Herbal Antioxidants: An Overview |
| Q37843783 | Drug-induced autoimmune-like hepatitis |
| Q38068354 | Drug-induced liver injury in the elderly |
| Q38084215 | Drug-induced liver injury: the role of drug metabolism and transport |
| Q37510856 | Drug-induced liver injury: what was new in 2008? |
| Q38254730 | Effect of drug transporter pharmacogenetics on cholestasis |
| Q33990236 | Epidemiology of idiosyncratic drug-induced liver injury |
| Q27027301 | Evaluation of database-derived pathway development for enabling biomarker discovery for hepatotoxicity |
| Q37624916 | Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations |
| Q64227701 | Herb induced liver injury after using herbal medicine: A systemic review and case-control study |
| Q50048303 | Levonorgestrel-Releasing Intrauterine Device-Related Acute Liver Injury |
| Q26781801 | MicroRNAs in Drug-induced Liver Injury |
| Q92377619 | Novel circulating- and imaging-based biomarkers to enhance the mechanistic understanding of human drug-induced liver injury |
| Q33962491 | Paracetamol in therapeutic dosages and acute liver injury: causality assessment in a prospective case series. |
| Q37341906 | Practical guidelines for diagnosis and early management of drug-induced liver injury |
| Q37771029 | Predicting and preventing acute drug-induced liver injury: what's new in 2010? |
| Q46082185 | Probable enoxaparin-induced hepatotoxicity |
| Q38057354 | Review article: herbal and dietary supplement hepatotoxicity |
| Q35168108 | Risk factors for idiosyncratic drug-induced liver injury |
| Q35778423 | Spontaneously reported hepatic adverse drug events in Korea: multicenter study |
| Q24658613 | Standardizing in vitro diagnostics tasks in clinical trials: a call for action |
| Q48145497 | Statin drug interactions and related adverse reactions: an update |
| Q43091229 | Terbinafine induced liver injury: a case report |
| Q90093408 | The Origins of the Modern-Day Study of Drug Hepatotoxicity: Focus on Hyman J. Zimmerman |
Search more.